BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Apte UM, Banerjee A, McRee R, Wellberg E, Ramaiah SK. Role of osteopontin in hepatic neutrophil infiltration during alcoholic steatohepatitis. Toxicol Appl Pharmacol. 2005;207:25-38. [PMID: 15885730 DOI: 10.1016/j.taap.2004.12.018] [Cited by in Crossref: 83] [Cited by in F6Publishing: 76] [Article Influence: 5.2] [Reference Citation Analysis]
Number Citing Articles
1 Wang G, Zhao C, Chen S, Li X, Zhang L, Chang C, Xu C. A preliminary in vivo study of the effects of OPN on rat liver regeneration induced by partial hepatectomy. Mol Biol Rep 2016;43:1371-82. [PMID: 27585571 DOI: 10.1007/s11033-016-4071-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
2 Tu Y, Zhu S, Wang J, Burstein E, Jia D. Natural compounds in the chemoprevention of alcoholic liver disease. Phytother Res 2019;33:2192-212. [PMID: 31264302 DOI: 10.1002/ptr.6410] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
3 Sahai A, Pan X, Paul R, Malladi P, Kohli R, Whitington PF. Roles of phosphatidylinositol 3-kinase and osteopontin in steatosis and aminotransferase release by hepatocytes treated with methionine-choline-deficient medium. Am J Physiol Gastrointest Liver Physiol. 2006;291:G55-G62. [PMID: 16439472 DOI: 10.1152/ajpgi.00360.2005] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
4 Lazaro R, Wu R, Lee S, Zhu NL, Chen CL, French SW, Xu J, Machida K, Tsukamoto H. Osteopontin deficiency does not prevent but promotes alcoholic neutrophilic hepatitis in mice. Hepatology. 2015;61:129-140. [PMID: 25132354 DOI: 10.1002/hep.27383] [Cited by in Crossref: 77] [Cited by in F6Publishing: 69] [Article Influence: 11.0] [Reference Citation Analysis]
5 Ramaiah SK, Jaeschke H. Role of neutrophils in the pathogenesis of acute inflammatory liver injury. Toxicol Pathol. 2007;35:757-766. [PMID: 17943649 DOI: 10.1080/01926230701584163] [Cited by in Crossref: 226] [Cited by in F6Publishing: 217] [Article Influence: 17.4] [Reference Citation Analysis]
6 Arjomandi M, Frelinger J, Donde A, Wong H, Yellamilli A, Raymond W. Secreted osteopontin is highly polymerized in human airways and fragmented in asthmatic airway secretions. PLoS One 2011;6:e25678. [PMID: 22031818 DOI: 10.1371/journal.pone.0025678] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
7 Luyendyk J, Roth R, Ganey P. Inflammation and Hepatotoxicity. Comprehensive Toxicology. Elsevier; 2010. pp. 295-317. [DOI: 10.1016/b978-0-08-046884-6.01031-9] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
8 Mandarapu R, Prakhya BM. Exposure to cypermethrin and mancozeb alters the expression profile of THBS1, SPP1, FEZ1 and GPNMB in human peripheral blood mononuclear cells. J Immunotoxicol 2016;13:463-73. [PMID: 26796295 DOI: 10.3109/1547691X.2015.1130088] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
9 Urtasun R, Lopategi A, George J, Leung TM, Lu Y, Wang X, Ge X, Fiel MI, Nieto N. Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin α(V)β(3) engagement and PI3K/pAkt/NFκB signaling. Hepatology. 2012;55:594-608. [PMID: 21953216 DOI: 10.1002/hep.24701] [Cited by in Crossref: 140] [Cited by in F6Publishing: 137] [Article Influence: 15.6] [Reference Citation Analysis]
10 Singh R, Hui T, Matsui A, Allahem Z, Johnston CD, Ruiz-Torruella M, Rittling SR. Modulation of infection-mediated migration of neutrophils and CXCR2 trafficking by osteopontin. Immunology 2017;150:74-86. [PMID: 27599164 DOI: 10.1111/imm.12668] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
11 Maricic I, Sheng H, Marrero I, Seki E, Kisseleva T, Chaturvedi S, Molle N, Mathews SA, Gao B, Kumar V. Inhibition of type I natural killer T cells by retinoids or following sulfatide-mediated activation of type II natural killer T cells attenuates alcoholic liver disease in mice. Hepatology 2015;61:1357-69. [PMID: 25477000 DOI: 10.1002/hep.27632] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 8.7] [Reference Citation Analysis]
12 Yasmin A, Regan DP, Schook LB, Gaba RC, Schachtschneider KM. Transcriptional regulation of alcohol induced liver fibrosis in a translational porcine hepatocellular carcinoma model. Biochimie 2021;182:73-84. [PMID: 33444661 DOI: 10.1016/j.biochi.2020.12.022] [Reference Citation Analysis]
13 Gyamfi MA, Wan YJ. Pathogenesis of alcoholic liver disease: the role of nuclear receptors. Exp Biol Med (Maywood). 2010;235:547-560. [PMID: 20463294 DOI: 10.1258/ebm.2009.009249] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 4.6] [Reference Citation Analysis]
14 Fernando H, Kondraganti S, Bhopale KK, Volk DE, Neerathilingam M, Kaphalia BS, Luxon BA, Boor PJ, Shakeel Ansari GA. ¹H and ³¹P NMR lipidome of ethanol-induced fatty liver. Alcohol Clin Exp Res 2010;34:1937-47. [PMID: 20682011 DOI: 10.1111/j.1530-0277.2010.01283.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 4.6] [Reference Citation Analysis]
15 Bruha R, Vitek L, Smid V. Osteopontin - A potential biomarker of advanced liver disease. Ann Hepatol 2020;19:344-52. [PMID: 32005637 DOI: 10.1016/j.aohep.2020.01.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
16 Nagoshi S. Osteopontin: Versatile modulator of liver diseases. Hepatol Res. 2014;44:22-30. [PMID: 23701387 DOI: 10.1111/hepr.12166] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 7.0] [Reference Citation Analysis]
17 Atai NA, Bansal M, Lo C, Bosman J, Tigchelaar W, Bosch KS, Jonker A, De Witt Hamer PC, Troost D, McCulloch CA, Everts V, Van Noorden CJ, Sodek J. Osteopontin is up-regulated and associated with neutrophil and macrophage infiltration in glioblastoma. Immunology 2011;132:39-48. [PMID: 20722758 DOI: 10.1111/j.1365-2567.2010.03335.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 5.2] [Reference Citation Analysis]
18 van der Windt GJW, Hoogendijk AJ, Schouten M, Hommes TJ, de Vos AF, Florquin S, van der Poll T. Osteopontin Impairs Host Defense During Pneumococcal Pneumonia. The Journal of Infectious Diseases 2011;203:1850-8. [DOI: 10.1093/infdis/jir185] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
19 Wang C, He M, Peng J, Li S, Long M, Chen W, Liu D, Yang G, Zhang L. Increased plasma osteopontin levels are associated with nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. Cytokine. 2020;125:154837. [PMID: 31514105 DOI: 10.1016/j.cyto.2019.154837] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
20 Ramaiah SK, Jaeschke H. Hepatic Neutrophil Infiltration in the Pathogenesis of Alcohol-Induced Liver Injury. Toxicology Mechanisms and Methods 2008;17:431-40. [DOI: 10.1080/00952990701407702] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 2.9] [Reference Citation Analysis]
21 Magdaleno F, Ge X, Fey H, Lu Y, Gaskell H, Blajszczak CC, Aloman C, Fiel MI, Nieto N. Osteopontin deletion drives hematopoietic stem cell mobilization to the liver and increases hepatic iron contributing to alcoholic liver disease. Hepatol Commun 2018;2:84-98. [PMID: 29404515 DOI: 10.1002/hep4.1116] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
22 Takada H, Nakazawa T, Ohara H, Ando T, Hayashi K, Naito I, Okumura F, Tanaka H, Yamada T, Takahashi S, Joh T. Role of Osteopontin in Calcification in Autoimmune Pancreatitis. Dig Dis Sci 2009;54:793-801. [DOI: 10.1007/s10620-008-0418-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
23 Wang Y, Liu Y. Neutrophil-Induced Liver Injury and Interactions Between Neutrophils and Liver Sinusoidal Endothelial Cells. Inflammation 2021;44:1246-62. [PMID: 33649876 DOI: 10.1007/s10753-021-01442-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Bhopale KK, Kondraganti S, Fernando H, Boor PJ, Kaphalia BS, Shakeel Ansari GA. Alcoholic Steatosis in Different Strains of Rat: A Comparative Study. J Drug Alcohol Res 2015;4:235912. [PMID: 27213081 DOI: 10.4303/jdar/235912] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
25 Ramaiah SK, Rittling S. Role of osteopontin in regulating hepatic inflammatory responses and toxic liver injury. Expert Opinion on Drug Metabolism & Toxicology 2007;3:519-26. [DOI: 10.1517/17425255.3.4.519] [Cited by in Crossref: 34] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
26 Zhou N, Wang K, Fang S, Zhao X, Huang T, Chen H, Yan F, Tang Y, Zhou H, Zhu J. Discovery of a Potential Plasma Protein Biomarker Panel for Acute-on-Chronic Liver Failure Induced by Hepatitis B Virus. Front Physiol 2017;8:1009. [PMID: 29270132 DOI: 10.3389/fphys.2017.01009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
27 Banerjee A, Russell WK, Jayaraman A, Ramaiah SK. Identification of proteins to predict the molecular basis for the observed gender susceptibility in a rat model of alcoholic steatohepatitis by 2-D gel proteomics. Proteomics. 2008;8:4327-4337. [PMID: 18924223 DOI: 10.1002/pmic.200700368] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
28 Banerjee A, Apte UM, Smith R, Ramaiah SK. Higher neutrophil infiltration mediated by osteopontin is a likely contributing factor to the increased susceptibility of females to alcoholic liver disease. J Pathol. 2006;208:473-485. [PMID: 16440289 DOI: 10.1002/path.1917] [Cited by in Crossref: 75] [Cited by in F6Publishing: 69] [Article Influence: 5.0] [Reference Citation Analysis]
29 Chen BL, Zhang GY, Yuan WJ, Wang SP, Shen YM, Yan L, Gu H, Li J. Osteopontin expression is associated with hepatopathologic changes in Schistosoma japonicum infected mice. World J Gastroenterol 2011; 17(46): 5075-5082 [PMID: 22171141 DOI: 10.3748/wjg.v17.i46.5075] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
30 Seth D, Gorrell MD, Cordoba S, McCaughan GW, Haber PS. Intrahepatic gene expression in human alcoholic hepatitis. J Hepatol. 2006;45:306-320. [PMID: 16797773 DOI: 10.1016/j.jhep.2006.04.013] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 3.3] [Reference Citation Analysis]
31 Wang KX, Denhardt DT. Osteopontin: role in immune regulation and stress responses. Cytokine Growth Factor Rev. 2008;19:333-345. [PMID: 18952487 DOI: 10.1016/j.cytogfr.2008.08.001] [Cited by in Crossref: 439] [Cited by in F6Publishing: 422] [Article Influence: 33.8] [Reference Citation Analysis]
32 Patouraux S, Bonnafous S, Voican CS, Anty R, Saint-Paul MC, Rosenthal-Allieri MA, Agostini H, Njike M, Barri-Ova N, Naveau S, Le Marchand-Brustel Y, Veillon P, Calès P, Perlemuter G, Tran A, Gual P. The osteopontin level in liver, adipose tissue and serum is correlated with fibrosis in patients with alcoholic liver disease. PLoS One 2012;7:e35612. [PMID: 22530059 DOI: 10.1371/journal.pone.0035612] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 6.4] [Reference Citation Analysis]
33 Mathews S, Xu M, Wang H, Bertola A, Gao B. Animals models of gastrointestinal and liver diseases. Animal models of alcohol-induced liver disease: pathophysiology, translational relevance, and challenges. Am J Physiol Gastrointest Liver Physiol. 2014;306:G819-G823. [PMID: 24699333 DOI: 10.1152/ajpgi.00041.2014] [Cited by in Crossref: 82] [Cited by in F6Publishing: 76] [Article Influence: 11.7] [Reference Citation Analysis]
34 Williams JA, Manley S, Ding WX. New advances in molecular mechanisms and emerging therapeutic targets in alcoholic liver diseases. World J Gastroenterol 2014; 20(36): 12908-12933 [PMID: 25278688 DOI: 10.3748/wjg.v20.i36.12908] [Cited by in CrossRef: 56] [Cited by in F6Publishing: 54] [Article Influence: 8.0] [Reference Citation Analysis]
35 Lee JH, Banerjee A, Ueno Y, Ramaiah SK. Potential relationship between hepatobiliary osteopontin and peroxisome proliferator-activated receptor alpha expression following ethanol-associated hepatic injury in vivo and in vitro. Toxicol Sci. 2008;106:290-299. [PMID: 18703563 DOI: 10.1093/toxsci/kfn165] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
36 Seth D, Duly A, Kuo PC, McCaughan GW, Haber PS. Osteopontin is an important mediator of alcoholic liver disease via hepatic stellate cell activation. World J Gastroenterol 2014; 20(36): 13088-13104 [PMID: 25278703 DOI: 10.3748/wjg.v20.i36.13088] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 28] [Article Influence: 4.6] [Reference Citation Analysis]
37 Banerjee A, Lee JH, Ramaiah SK. Interaction of osteopontin with neutrophil alpha(4)beta(1) and alpha(9)beta(1) integrins in a rodent model of alcoholic liver disease. Toxicol Appl Pharmacol 2008;233:238-46. [PMID: 18778724 DOI: 10.1016/j.taap.2008.08.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
38 Yang M, Ramachandran A, Yan HM, Woolbright BL, Copple BL, Fickert P, Trauner M, Jaeschke H. Osteopontin is an initial mediator of inflammation and liver injury during obstructive cholestasis after bile duct ligation in mice. Toxicol Lett 2014;224:186-95. [PMID: 24188933 DOI: 10.1016/j.toxlet.2013.10.030] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 5.0] [Reference Citation Analysis]
39 Purohit V, Bode JC, Bode C, Brenner DA, Choudhry MA, Hamilton F, Kang YJ, Keshavarzian A, Rao R, Sartor RB, Swanson C, Turner JR. Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: summary of a symposium. Alcohol 2008;42:349-61. [PMID: 18504085 DOI: 10.1016/j.alcohol.2008.03.131] [Cited by in Crossref: 198] [Cited by in F6Publishing: 185] [Article Influence: 15.2] [Reference Citation Analysis]
40 Nishimichi N, Higashikawa F, Kinoh HH, Tateishi Y, Matsuda H, Yokosaki Y. Polymeric osteopontin employs integrin alpha9beta1 as a receptor and attracts neutrophils by presenting a de novo binding site. J Biol Chem 2009;284:14769-76. [PMID: 19346516 DOI: 10.1074/jbc.M901515200] [Cited by in Crossref: 40] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
41 Voican CS, Perlemuter G, Naveau S. Mechanisms of the inflammatory reaction implicated in alcoholic hepatitis: 2011 update. Clin Res Hepatol Gastroenterol. 2011;35:465-474. [PMID: 21571602 DOI: 10.1016/j.clinre.2011.01.017] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
42 Fickert P, Thueringer A, Moustafa T, Silbert D, Gumhold J, Tsybrovskyy O, Lebofsky M, Jaeschke H, Denk H, Trauner M. The role of osteopontin and tumor necrosis factor alpha receptor-1 in xenobiotic-induced cholangitis and biliary fibrosis in mice. Lab Invest. 2010;90:844-852. [PMID: 20368698 DOI: 10.1038/labinvest.2010.61] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
43 Kong LZ, Chandimali N, Han YH, Lee DH, Kim JS, Kim SU, Kim TD, Jeong DK, Sun HN, Lee DS, Kwon T. Pathogenesis, Early Diagnosis, and Therapeutic Management of Alcoholic Liver Disease. Int J Mol Sci 2019;20:E2712. [PMID: 31159489 DOI: 10.3390/ijms20112712] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 15.5] [Reference Citation Analysis]
44 Huang W, Zhu G, Huang M, Lou G, Liu Y, Wang S. Plasma osteopontin concentration correlates with the severity of hepatic fibrosis and inflammation in HCV-infected subjects. Clin Chim Acta. 2010;411:675-678. [PMID: 20138033 DOI: 10.1016/j.cca.2010.01.029] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 3.3] [Reference Citation Analysis]
45 Nguyen H, Sankaran S, Dandekar S. Hepatitis C virus core protein induces expression of genes regulating immune evasion and anti-apoptosis in hepatocytes. Virology. 2006;354:58-68. [PMID: 16876223 DOI: 10.1016/j.virol.2006.04.028] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 3.1] [Reference Citation Analysis]
46 Li S, Tan HY, Wang N, Feng Y, Wang X. Recent Insights Into the Role of Immune Cells in Alcoholic Liver Disease.Front Immunol. 2019;10:1328. [PMID: 31244862 DOI: 10.3389/fimmu.2019.01328] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
47 Bischoff K, Mukai M, Ramaiah SK. Liver Toxicity. Veterinary Toxicology. Elsevier; 2018. pp. 239-57. [DOI: 10.1016/b978-0-12-811410-0.00015-5] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
48 Woolbright BL, Jaeschke H. Therapeutic targets for cholestatic liver injury. Expert Opin Ther Targets 2016;20:463-75. [PMID: 26479335 DOI: 10.1517/14728222.2016.1103735] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
49 Petrasek J, Csak T, Szabo G. Toll-like receptors in liver disease. Adv Clin Chem. 2013;59:155-201. [PMID: 23461136 DOI: 10.1016/b978-0-12-405211-6.00006-1] [Cited by in Crossref: 53] [Cited by in F6Publishing: 32] [Article Influence: 6.6] [Reference Citation Analysis]
50 Milošević N, Rütter M, Ventura Y, Kezerle Y, Feinshtein V, David A. Attenuation of neutrophil-mediated liver injury in mice by drug-free E-selectin binding polymer. J Control Release 2020;319:475-86. [PMID: 31838202 DOI: 10.1016/j.jconrel.2019.12.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
51 Bhushan B, Borude P, Edwards G, Walesky C, Cleveland J, Li F, Ma X, Apte U. Role of bile acids in liver injury and regeneration following acetaminophen overdose. Am J Pathol 2013;183:1518-26. [PMID: 24007882 DOI: 10.1016/j.ajpath.2013.07.012] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 5.3] [Reference Citation Analysis]
52 Xu MJ, Zhou Z, Parker R, Gao B. Targeting inflammation for the treatment of alcoholic liver disease. Pharmacol Ther 2017;180:77-89. [PMID: 28642119 DOI: 10.1016/j.pharmthera.2017.06.007] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 7.3] [Reference Citation Analysis]
53 Fernando H, Bhopale KK, Kondraganti S, Kaphalia BS, Shakeel Ansari GA. Lipidomic changes in rat liver after long-term exposure to ethanol. Toxicol Appl Pharmacol 2011;255:127-37. [PMID: 21736892 DOI: 10.1016/j.taap.2011.05.022] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 4.8] [Reference Citation Analysis]
54 Ramaiah SK, Rittling S. Pathophysiological role of osteopontin in hepatic inflammation, toxicity, and cancer. Toxicol Sci. 2008;103:4-13. [PMID: 17890765 DOI: 10.1093/toxsci/kfm246] [Cited by in Crossref: 119] [Cited by in F6Publishing: 108] [Article Influence: 8.5] [Reference Citation Analysis]
55 Ingawale DK, Mandlik SK, Naik SR. Models of hepatotoxicity and the underlying cellular, biochemical and immunological mechanism(s): a critical discussion. Environ Toxicol Pharmacol. 2014;37:118-133. [PMID: 24322620 DOI: 10.1016/j.etap.2013.08.015] [Cited by in Crossref: 99] [Cited by in F6Publishing: 89] [Article Influence: 12.4] [Reference Citation Analysis]
56 Seth D, Haber PS, Syn WK, Diehl AM, Day CP. Pathogenesis of alcohol-induced liver disease: classical concepts and recent advances. J Gastroenterol Hepatol. 2011;26:1089-1105. [PMID: 21545524 DOI: 10.1111/j.1440-1746.2011.06756.x] [Cited by in Crossref: 100] [Cited by in F6Publishing: 89] [Article Influence: 10.0] [Reference Citation Analysis]
57 Petrasek J, Mandrekar P, Szabo G. Toll-like receptors in the pathogenesis of alcoholic liver disease. Gastroenterol Res Pract. 2010;2010:710381. [PMID: 20827314 DOI: 10.1155/2010/710381] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 5.5] [Reference Citation Analysis]
58 Szabo G, Bala S. Alcoholic liver disease and the gut-liver axis. World J Gastroenterol 2010; 16(11): 1321-1329 [PMID: 20238398 DOI: 10.3748/wjg.v16.i11.1321] [Cited by in CrossRef: 233] [Cited by in F6Publishing: 216] [Article Influence: 21.2] [Reference Citation Analysis]
59 Adams DH, Ju C, Ramaiah SK, Uetrecht J, Jaeschke H. Mechanisms of immune-mediated liver injury. Toxicol Sci. 2010;115:307-321. [PMID: 20071422 DOI: 10.1093/toxsci/kfq009] [Cited by in Crossref: 201] [Cited by in F6Publishing: 177] [Article Influence: 18.3] [Reference Citation Analysis]
60 Wang W, Li F, Wang K, Cheng B, Guo X. PAPSS2 promotes alkaline phosphates activity and mineralization of osteoblastic MC3T3-E1 cells by crosstalk and Smads signal pathways. PLoS One 2012;7:e43475. [PMID: 22916269 DOI: 10.1371/journal.pone.0043475] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
61 Jovic S, Shikhagaie M, Mörgelin M, Erjefält JS, Kjellström S, Egesten A. Osteopontin is increased in cystic fibrosis and can skew the functional balance between ELR-positive and ELR-negative CXC-chemokines. Journal of Cystic Fibrosis 2015;14:453-63. [DOI: 10.1016/j.jcf.2014.11.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
62 Nishimichi N, Hayashita-Kinoh H, Chen C, Matsuda H, Sheppard D, Yokosaki Y. Osteopontin undergoes polymerization in vivo and gains chemotactic activity for neutrophils mediated by integrin alpha9beta1. J Biol Chem 2011;286:11170-8. [PMID: 21321126 DOI: 10.1074/jbc.M110.189258] [Cited by in Crossref: 39] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
63 Simão A, Madaleno J, Silva N, Rodrigues F, Caseiro P, Costa JN, Carvalho A. Plasma osteopontin is a biomarker for the severity of alcoholic liver cirrhosis, not for hepatocellular carcinoma screening. BMC Gastroenterol 2015;15:73. [PMID: 26122937 DOI: 10.1186/s12876-015-0307-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
64 Hakansson A, Molin G. Gut microbiota and inflammation. Nutrients. 2011;3:637-682. [PMID: 22254115 DOI: 10.3390/nu3060637] [Cited by in Crossref: 217] [Cited by in F6Publishing: 195] [Article Influence: 21.7] [Reference Citation Analysis]
65 Cheng D, Xie MZ. A review of a potential and promising probiotic candidate-Akkermansia muciniphila. J Appl Microbiol 2021;130:1813-22. [PMID: 33113228 DOI: 10.1111/jam.14911] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
66 Grander C, Adolph TE, Wieser V, Lowe P, Wrzosek L, Gyongyosi B, Ward DV, Grabherr F, Gerner RR, Pfister A, Enrich B, Ciocan D, Macheiner S, Mayr L, Drach M, Moser P, Moschen AR, Perlemuter G, Szabo G, Cassard AM, Tilg H. Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease. Gut. 2018;67:891-901. [PMID: 28550049 DOI: 10.1136/gutjnl-2016-313432] [Cited by in Crossref: 192] [Cited by in F6Publishing: 182] [Article Influence: 48.0] [Reference Citation Analysis]
67 Xie Y, Wang H, Cheng X, Wu Y, Cao L, Wu M, Xie W, Wang G, Hao H. Farnesoid X receptor activation promotes cell proliferation via PDK4-controlled metabolic reprogramming. Sci Rep 2016;6:18751. [PMID: 26728993 DOI: 10.1038/srep18751] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
68 Banerjee A, Burghardt RC, Johnson GA, White FJ, Ramaiah SK. The temporal expression of osteopontin (SPP-1) in the rodent model of alcoholic steatohepatitis: a potential biomarker. Toxicol Pathol. 2006;34:373-384. [PMID: 16844665 DOI: 10.1080/01926230600806543] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
69 Zhong Z, Lemasters JJ. A Unifying Hypothesis Linking Hepatic Adaptations for Ethanol Metabolism to the Proinflammatory and Profibrotic Events of Alcoholic Liver Disease. Alcohol Clin Exp Res 2018;42:2072-89. [PMID: 30132924 DOI: 10.1111/acer.13877] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
70 Lixin X, Lijun Y, Songping H. Ganoderic acid A against cyclophosphamide‐induced hepatic toxicity in mice. J Biochem Mol Toxicol 2018;33:e22271. [DOI: 10.1002/jbt.22271] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
71 Wang W, Li P, Li W, Jiang J, Cui Y, Li S, Wang Z. Osteopontin activates mesenchymal stem cells to repair skin wound. PLoS One 2017;12:e0185346. [PMID: 28957406 DOI: 10.1371/journal.pone.0185346] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
72 Jaeschke H, Hasegawa T. Role of neutrophils in acute inflammatory liver injury. Liver Int. 2006;26:912-919. [PMID: 16953830 DOI: 10.1111/j.1478-3231.2006.01327.x] [Cited by in Crossref: 167] [Cited by in F6Publishing: 162] [Article Influence: 11.9] [Reference Citation Analysis]
73 袁运生, 谢旻旗, 钱正昊, 张夕原, 严德珺, 俞雁. 骨桥蛋白: 肝脏疾病中的一个重要分子. 世界华人消化杂志 2011; 19(8): 814-819 [DOI: 10.11569/wcjd.v19.i8.814] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
74 Seth D, D’souza El-guindy NB, Apte M, Mari M, Dooley S, Neuman M, Haber PS, Kundu GC, Darwanto A, de Villiers WJ, Vonlaufen A, Xu Z, Phillips P, Yang S, Goldstein D, Pirola RM, Wilson JS, Moles A, Fernã¡ndez A, Colell A, Garcã­a-ruiz C, Fernã¡ndez-checa JC, Meyer C, Meindl-beinker NM. Alcohol, Signaling, and ECM Turnover. Alcoholism: Clinical and Experimental Research 2010;34:4-18. [DOI: 10.1111/j.1530-0277.2009.01060.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
75 Banerjee A, Rose R, Johnson GA, Burghardt RC, Ramaiah SK. The Influence of Estrogen on Hepatobiliary Osteopontin (SPP1) Expression in a Female Rodent Model of Alcoholic Steatohepatitis. Toxicol Pathol 2009;37:492-501. [DOI: 10.1177/0192623309335633] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
76 Ge X, Leung TM, Arriazu E, Lu Y, Urtasun R, Christensen B, Fiel MI, Mochida S, Sørensen ES, Nieto N. Osteopontin binding to lipopolysaccharide lowers tumor necrosis factor-α and prevents early alcohol-induced liver injury in mice. Hepatology. 2014;59:1600-1616. [PMID: 24214181 DOI: 10.1002/hep.26931] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 5.0] [Reference Citation Analysis]